molybdenum has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batinic-Haberle, I; Briehl, MM; Glinsmann-Gibson, B; Lee, K; Mazar, AP; Reboucas, JS; Rimsza, LM; Tome, ME | 1 |
1 other study(ies) available for molybdenum and Hematologic Malignancies
| Article | Year |
|---|---|
The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies.
Topics: Animals; B-Lymphocytes; Cell Death; Cell Survival; Chelating Agents; Copper; Hematologic Neoplasms; Humans; Mice; Molybdenum; Oxidative Stress; Peroxynitrous Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Cell Culture; Proto-Oncogene Proteins c-bcl-2; Stress, Physiological; Superoxide Dismutase; Superoxide Dismutase-1; U937 Cells | 2013 |